Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study

por Cantini, Fabrizio, Niccoli, Laura, Cassarà, Emanuele, Kaloudi, Olga, Nannini, Carlotta
Publicado 2012

Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

por Cantini, Fabrizio, Niccoli, Laura, Cassarà, Emanuele, Kaloudi, Olga, Nannini, Carlotta
Publicado 2013

Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report

por Niccoli, Laura, Cassarà, Emanuele, Kaloudi, Olga, Nannini, Carlotta, Romagnoli, Micaela, Cantini, Fabrizio
Publicado 2015

Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

por Cantini, Fabrizio, Niccoli, Laura, Nannini, Carlotta, Kaloudi, Olga, Cassarà, Emanuele, Susini, Massimo, Lenzetti, Ivo
Publicado 2012

Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables

por Niccoli, Laura, Nannini, Carlotta, Blandizzi, Corrado, Mantarro, Stefania, Mosca, Marta, Di Munno, Ombretta, Goletti, Delia, Benucci, Maurizio, Gobbi, Francesca Li, Cassarà, Emanuele, Kaloudi, Olga, Cantini, Fabrizio
Publicado 2018